home

Boehringer sees turbocharged diabetes unit driving future growth

FrontierBoehringer2016-04-26 16:51 Read   196

When Boehringer Ingelheim announced its 2015 financial results last week, it spotlighted growth in multiple therapeutic areas.

Daiichi Sankyo, Inc. To Establish New U.S. Headquarters in Basking Ridge, New Jersey

FrontierDaiichi Sankyo2016-04-26 16:38 Read   161

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Company, Ltd., today announced that it will establish a new U.S. headquarters, co-locating its commercial and development divisions in Basking Ridge, NJ.

Pfizer's Chantix not linked to serious psychiatric side effects: Study

Frontierfiercepharma2016-04-26 13:30 Read   120

Pfizer ($PFE) has been trying to get the FDA to take the black box warning off its smoking cessation drug, Chantix, after regulators warned that the med could be linked to serious psychiatric side effects.

Ascentage Pharma and UNITY Biotechnology Announce Collaboration for the Development of Senolytic Healthspan Therapies

Frontierprnewswire2016-04-26 09:58 Read   139

Ascentage Pharma, a clinical-stage biopharmaceutical company focused on apoptosis-targeted oncology drug discovery and development, and UNITY Biotechnology, a San Francisco-based biopharmaceutical company focused on the development of medicines to improve healthspan, announced a worldwide collaboration to develop senolytic treatments for age-related disease.

Dotmatics and eMolecules Announce Partnership to Deliver Next Generation Intelligent Chemical Sourcing

Frontierdotmatics2016-04-26 09:52 Read   131

New component combines eMolecules’ federated collection of commercially available chemicals with the power of Dotmatics’ flexible search

AstraZeneca sets out to build 5-petabyte, 2M-genome database

Frontierfiercebiotech2016-04-26 09:27 Read   123

AstraZeneca ($AZN) is redefining what big looks like in genome research. While a range of initiatives have been branded population-scale sequencing programs, none wear the label quite as comfortably as AstraZeneca’s scheme.

Toxicity, second cancers cause researchers to question radiation’s role in Hodgkin lymphoma

Frontierhealio2016-04-25 16:52 Read   108

Radiation therapy has been an integral part of treatment for patients with early-stage Hodgkin lymphoma since the 1960s.

Propensity matching and the GIGO principle

Frontierhealio2016-04-25 16:48 Read   140

It has become much harder to be a rational person with a modicum of biostatistical knowledge who can refrain from becoming irritated in the current “academic” oncology environment.

Probing Gut Microbiome, Second Genome Nabs $43M To Push Colitis Drug

Frontierxconomy2016-04-21 14:55 Read   77

econd Genome, a South San Francisco, CA-based biotech using microbiome research to develop traditional small-molecule drugs, has tapped an unusual group of private investors for nearly $43 million in a Series B round of financing.

Pharma digital spending ticks upward slowly but surely

Frontierfiercepharma2016-04-21 13:51 Read   86

Digital spending is expected to overtake TV media spending in the advertising industry this year, but for the pharma industry that’s not nearly true yet. Drug marketers are beginning to shift, however, if only at the slow speed customary in the pharma world.

BioMarin says hemophilia A gene therapy data 'encouraging'

Frontierfiercebiotech2016-04-21 10:56 Read   78

Badly in need of a win, BioMarin ($BMRN) released what it described as encouraging midstage data from a small study today showing its blood disorder gene therapy saw high factor VIII rates--but raised liver enzymes were noted.

Scientists propose treatment for severe lung diseases

Frontiereurekalert2016-04-21 10:34 Read   82

Researchers are developing a new drug to treat life-threatening lung damage and breathing problems in people with severe infections like pneumonia, those undergoing certain cancer treatments and premature infants with underdeveloped, injury prone lungs.